Lumida
/DOUG
⌘K
Douglas Elliman Inc

Douglas Elliman Inc

DOUG
$1.73USD↑+0.58%+0.01 today

MARKET CAP

157.2M

P/E (TTM)

34.6x

FWD P/E

—

DAY RANGE

$2 – $2

52W RANGE

$2
$3

AI Summary

Stalk
TrimMedium

The asset remains in a Stage 4 decline with failed rallies at declining EMAs, confirming a bearish medium-term bias. Short-term price is neutral, trading sideways below sloping EMAs and lacking a clear bounce signal. Execution should be deferred and focused on trimming into rallies back into the 9 EMA and 21 EMA zone for rejection at resistance.

  • ↑Q2 revenue grew 4.5% YoY to $283.4M while net loss shrank from $22.7M to $2.7M.
  • ↑General & admin expenses fell 32% YoY, boosting margin recovery.
  • ↓Stock trades at 37.9×P/E vs. industry’s 32.7×, signaling rich valuation.
Full analysis →

Buying

3

institutions

Selling

2

institutions

New Positions

0

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY5.36 M9.48 M+311.86 K+14.6%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL3.02 M5.34 M+-131.50 K+3.4%0.01%
AC

Aqr Capital Management LLC

Q2 2026

BUY742.47 K1.31 M+581.39 K+397.5%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY32.19 K57.94 K+2.00 K+17.8%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL12.30 K21.77 K+-109.50 K-89.1%0.00%